Internet 
Українська  English  Русский  

DOI: 10.31071/kit2017.13.13


Inventory reference ISSN 1812-7231 Klin.inform.telemed. Volume 12, Issue 13, 2017, Pages 105–112


Author(s) A. Tkachenko1, Р. Tkachenko2, V. Вооn2


Institution(s) 1National medical University. A. A. Bogomolets, Kiev 2National technical University of Ukraine "KPI", Kiev


Article title Using of mobile applications in the pharmacological correction of rheumatoid arthritis


Abstract (resume)

Introduction. Using of mobile applications in the pharmacological correction of rheumatoid arthritis is scientifically justified.

The purpose of the work. The justification of using of mobile applications in the pharmacological correction of rheumatoid arthritis.

Results and Discussion. The four main thematic areas of e-health: medical information systems, telemedicine, distance learning and mobile medicine have been present in the article. It has been established that the mobile medicine is a new cross-cutting trend that is developing rapidly. The most famous mobile applications, which are used in rheumatology, orthopedics, traumatology, cardiology, pulmonology and gastroenterology, have been present.

Conclusion. The necessity of the use of mobile applications by patients, doctors and medical students for training, an effective pharmacological correction of rheumatoid arthritis and related conditions, the electronic patient records management, the provision of medical consultations and monitoring the flow of chronic diseases have been proved.


Keywords medical applications, rheumatoid arthritis, comorbid conditions, doctors, medical students


References

1. Visser B.J., Korevaar D.A. and Nolan T. Mobile Medical apps: dangers and potential solutions. J. Telemed Telecare, 2013, vol.19, no.4, pp. 229–230.
https://doi.org/10.1177/1357633x13479706

2. Symmons D., Watson K., Silman A., Hyrich K. Baseline comorbidity levels in biologic and standard DMARD treated patients with rheumatoid arthritis: results from a national patient register. Ann. Rheum. Dis., 2006, no.65, pp. 895–898.

3. Radner H., Smolen J.S., Aletaha D. Impact of comorbidity on physical function in patients with rheumatoid arthritis. Ann. Rheum. Dis., 2010, vol.69, no.3, pp. 536–541.
https://doi.org/10.1136/ard.2009.118430

4. Turesson C., McClelland L., Teresa J.H. No decrease over time in the incidence of vasculitis or other extraarticular manifestations in rheumatoid arthritis: Results from a community-based study. Arthritis Rheum., 2004, vol.50, no.11, pp. 3729–3731.
https://doi.org/10.1002/art.20590

5. Belov B.S., Balabanova R.M., Manukyani S.G. Komorbidnyie infektsii pri revmaticheskih zabolevaniyah: sovremennoe sostoyanie problemyi [Comorbid infections in rheumatic diseases: state of the art]. Nauch.-prakt. revmatol, [Scientific-Practical Rheumatology], 2006, no.2, pp. 62–66. (In Russ.).

6. Kovalenko V.N. Revmatoidnyiy artrit. Diagnostika i lechenie [Rheumatoid Arthritis. Diagnosis and Treatment]. MORION Publ., 2001, 272 p. (In Russ.).

7. Kovalenko V.M., Bortkevich O.P., Protsenko G.O. Nesteroyidni protizapalni preparati: rol i mistse v suchasniy revmatologichniy praktitsi na osnovi danih dokazovoyi meditsini [Nonsteroidal anti-inflammatory drugs: the role and place in modern rheumatologic practice evidence-based medicine]. Ukrayinskiy revmatologichniy zhurnal [Ukrainian Journal of Rheumatology], 2006, no.1, pp. 17–29.

8. Mitchell J. From Telehealth to e-health: the unstoppable rise of e-health. Commonwealth Department of Communications, Information Technology and the Arts, 1999, 57 p.

9. Lewis T.L., Wyatt J.C. mHealthand Mobile Medical Apps: A Framework to Assess Risk and Promote Safer Use. J. MedInternetRes, 2014, vol.16, no.9, 210 p.

10. Hackethal V. 10 Top Mobile Apps for Rheumatoid Arthritis. The Journal of Musculoskeletal Medicine (Online), 2013.

11. Trinh J., Namil M., Weltmanet N. Examining the Impact of Providing Smartphones to Patients from a Managed Care Perspective: A Systematic Review. RAD, 2016, no.1642, 1 p.


Full-text version http://kit-journal.com.ua/en/viewer_en.html?doc/2017_13/012.pdf